These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 9825127)
21. Modification of avoidance responding by amphetamine and dopamine receptor antagonists. Jakubowska-Doğru E Pol J Pharmacol; 1999; 51(4):301-9. PubMed ID: 10540961 [TBL] [Abstract][Full Text] [Related]
22. Slow cortical potentials in human aversive trace conditioning. Hellwig S; Weisbrod M; Jochum V; Rentrop M; Unger J; Walther S; Haefner K; Roth A; Fiedler P; Bender S Int J Psychophysiol; 2008 Jul; 69(1):41-51. PubMed ID: 18485506 [TBL] [Abstract][Full Text] [Related]
23. Differential effects of dopamine and AMPA receptor antagonists on the expression of conditioned avoidance responding in rats. Boivin GA; Beninger RJ Behav Neurosci; 2008 Apr; 122(2):377-84. PubMed ID: 18410176 [TBL] [Abstract][Full Text] [Related]
24. The influence of dopamine agonists and antagonists on gastric lesions in mice. Sikirić P; Rotkvić I; Mise S; Krizanac S; Suchanek E; Petek M; Gjuris V; Geber J; Tućan-Foretić M; Udovicić I Eur J Pharmacol; 1987 Dec; 144(2):237-9. PubMed ID: 3436369 [TBL] [Abstract][Full Text] [Related]
25. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response. Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523 [TBL] [Abstract][Full Text] [Related]
26. Evidence for dopamine involvement in ambulation promoted by menthone in mice. Umezu T Pharmacol Biochem Behav; 2009 Jan; 91(3):315-20. PubMed ID: 18718482 [TBL] [Abstract][Full Text] [Related]
27. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Menon M; Jensen J; Vitcu I; Graff-Guerrero A; Crawley A; Smith MA; Kapur S Biol Psychiatry; 2007 Oct; 62(7):765-72. PubMed ID: 17224134 [TBL] [Abstract][Full Text] [Related]
28. Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization. Goto Y; Grace AA Neuron; 2005 Jul; 47(2):255-66. PubMed ID: 16039567 [TBL] [Abstract][Full Text] [Related]
30. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]
31. Developmental striatal critical period of activity-dependent plasticity is also a window of susceptibility for haloperidol induced adult motor alterations. Soiza-Reilly M; Azcurra JM Neurotoxicol Teratol; 2009; 31(4):191-7. PubMed ID: 19336253 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases. Li M; Parkes J; Fletcher PJ; Kapur S Pharmacol Biochem Behav; 2004 Aug; 78(4):811-9. PubMed ID: 15301940 [TBL] [Abstract][Full Text] [Related]
33. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors. Lo PS; Wu CY; Sue HZ; Chen HH Toxicology; 2009 Nov; 265(1-2):34-40. PubMed ID: 19765629 [TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. Charbit AR; Akerman S; Goadsby PJ J Pharmacol Exp Ther; 2009 Nov; 331(2):752-63. PubMed ID: 19657051 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. Nitsche MA; Lampe C; Antal A; Liebetanz D; Lang N; Tergau F; Paulus W Eur J Neurosci; 2006 Mar; 23(6):1651-7. PubMed ID: 16553629 [TBL] [Abstract][Full Text] [Related]
37. [Characteristics of effects of acetylene amino alcohols M-cholinoreceptor blockers on the dopaminergic system in Daphnia magna]. Kosmachev AB; Tonkopiĭ VD; Podosinovikova NP; Zagrebin AO; Evdokimova EA; Libman NM; Petrov VV; Dolgo-Saburov VB Eksp Klin Farmakol; 2000; 63(6):15-7. PubMed ID: 11202502 [TBL] [Abstract][Full Text] [Related]
38. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. Weinberger M; Mahant N; Hutchison WD; Lozano AM; Moro E; Hodaie M; Lang AE; Dostrovsky JO J Neurophysiol; 2006 Dec; 96(6):3248-56. PubMed ID: 17005611 [TBL] [Abstract][Full Text] [Related]